Lifecore Biomedical LFCR Q1 2026 Earnings Miss by Significant Key Takeaways GT Biopharma GTBP Q1 2026 Results Fall Short EPS 011 Revenue NA Markets Increase Odds of Fed Rate Hike After Hot Inflation Data Pricing Out Cuts Through 2027 Kevin Warsh Confirmed as Federal Reserve Chair in Historic Senate Vote Nvidia Stock Approaches Critical Technical Level as Traders Watch for Direction Most Americans Remain Skeptical of HumanCaused Climate Change Data Suggests Potential Market Risk MegaIPOs Could Signal Market Top as SpaceX and OpenAI Prep Record Floats QXO Launches Hostile Takeover Bid for Beacon After Repeated Rejections Perpetua Resources Secures 29 Billion Loan from US ExportImport Bank for Idaho Critical Minerals Project Fed Dissenters Kashkari Logan Hammack Explain Opposition to Rate Cut Signal Costamare Q1 2026 Earnings EPS Misses Estimates Shares Decline 42 KEP Q4 2025 Earnings EPS Miss Amid Operational Challenges HuBS Q1 2026 Earnings EPS Beats Estimates by 809 as Stock Declines OKUR Q1 2026 Earnings Wider EPS Loss Underscores Heavy RD Investment as PreRevenue Biotech Advances Pipeline AMZN Q1 2026 Earnings EPS Misses Estimates by 36 as Stock Climbs 079 POET Q1 2026 Earnings EPS Misses Expectations as Revenue Remains Unreported Nurix Therapeutics NRIX Modest Gains as Stock Approaches Key Resistance Blink Charging Co BLNK Surges Over 6 as Support Holds Near 079 Level Netflix NFLX Holds Near 88 as Consolidation Persists Soleno Therapeutics Holds Steady at 5301 Key Levels in Focus for SLNO Deere Company Rebounds Navigating Agricultural Cycles and Technical Levels Ultra Clean Holdings UCTT Gains 26 as Shares Approach Key Resistance Level MultiSensor AI Holdings Warrant MSAIW Stuck at 003 as trading remains listless Peraso Inc PRSO Surges 136 as Shares Test Key Resistance Levels Calamos Convertible Opportunities and Income Fund CHI Edges Higher Navigating Support and Resistance NET Power Inc NPWR Bounces from Support Eyes Key Resistance at 203 Launch Two Acquisition Corp LPBB Shows Modest Uptick Amid Low Volatility Telecom Stocks Surge on SpaceX IPO Hype but Historical Patterns Suggest Caution CDZI Q1 2026 Earnings NarrowerThanExpected Loss Improves Sentiment Acrivon Therapeutics ACRV Edges Higher Biotech Stock Tests Key Resistance at 177